CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Neurovive Pharmaceutical AB Company Snapshot
Neurovive Pharmaceutical AB operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Neurovive Pharmaceutical AB with three other miscellaneous service companies in Europe: Targovax ASA of Norway (2017 sales of 37,000.00 Norwegian Kroner [US$4,691.23 ] ), Immunovia AB (publ) (148,963.00 Swedish Kronor [US$17,483.79 ] ), and Xintela AB (2,000.00 Swedish Kronor [US$234.74 ] ).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Neurovive Pharmaceutical AB
  Stock Performance Chart for Neurovive Pharmaceutical AB
 
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 2.27
(Figures in Swedish Kronor)
1 Week 5.6%   13 Weeks -7.8%  
4 Weeks -23.1%   52 Weeks -37.8%  
 
Neurovive Pharmaceutical AB Key Data:
  Ticker: NVP Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 27,000
(Year Ending Jan 2018).
Employees: 15
  Currency: Swedish Kronor Market Cap: 132,739,188
  Fiscal Yr Ends: December Shares Outstanding: 58,475,413
  Share Type: Aktie Closely Held Shares: 17,678,826
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.